Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
11.76
Nov 06 • 3:59 PM ET Dollar change+0.08 Percentage change(0.68%)
Aftermarket Close
11.76
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
2.57B
Enterprise Value
3.17B
Income
-56.12M
Sales
883.99M
Book/sh
9.56
Cash/sh
0.79
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2636
IPO
Aug 23, 1989
P/E
-
Forward P/E
26.53
PEG
1.14
P/S
2.90
P/B
1.23
P/C
14.93
P/FCF
51.60
EV/EBITDA
26.94
EV/Sales
3.59
Quick Ratio
2.92
Current Ratio
3.90
Debt/Eq
0.37
LT Debt/Eq
0.37
Option/Short
Yes / Yes
EPS (ttm)
-0.26
EPS next Y
0.44
EPS next Q
0.06
EPS this Y
4.17%
EPS next Y
33.00%
EPS next 5Y
23.31%
EPS past 3/5Y
33.08% -
Sales past 3/5Y
1.91% 13.19%
EPS Y/Y TTM
94.64%
Sales Y/Y TTM
-0.33%
EPS Q/Q
-132.66%
Sales Q/Q
6.51%
Insider Own
0.99%
Insider Trans
-0.38%
Inst Own
109.97%
Inst Trans
2.68%
ROA
-1.68%
ROE
-2.67%
ROIC
-1.96%
Gross Margin
37.01%
Oper. Margin
0.01%
Profit Margin
-6.35%
SMA20
-1.98%
SMA50
-3.99%
SMA200
12.22%
Trades
Shs Outstand
218.30M
Shs Float
216.15M
52W High
14.26 -17.53%
52W Low
5.37 118.99%
Volatility
5.13% 4.20%
ATR (14)
0.57
RSI (14)
45.48
Beta
1.84
Rel Volume
0.73
Avg Volume
3.30M
Volume
2,408,428
Perf Week
-0.51%
Perf Month
0.43%
Perf Quarter
3.16%
Perf Half Y
29.94%
Perf YTD
68.24%
Perf Year
96.66%
Perf 3Y
-25.66%
Perf 5Y
-74.06%
Perf 10Y
-40.57%
Prev Close
11.68
Price
11.76
Change %
0.68%
Consensus
Buy
Avg. Price Target
$14.00
Implied Upside
+19.0%
Analysts7incl. previous ratings
Rating Distribution3 Buy · 4 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 26, 2026Upgrade
PPiper Sandler
Neutral → Overweight$14+19.0%
Jul 29, 2025Downgrade
WWilliam Blair
Outperform → Mkt Perform
Dec 19, 2024Initiated
GGuggenheim
Buy$15+27.6%
Jun 16, 2023Initiated
WFC logoWWells Fargo
Overweight$22+87.1%
Nov 22, 2022Upgrade
WWilliam Blair
Mkt Perform → Outperform
Jul 12, 2022Initiated
PPiper Sandler
Neutral$25+112.6%
May 23, 2019Initiated
GGuggenheim
Neutral
Dec 05, 2017Resumed
RROTH Capital
Neutral$82+597.3%
Jul 14, 2017Initiated
CCL King
Neutral
Jun 05, 2014Initiated
WWilliam Blair
Mkt Perform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yarwood JeremyChief Scientific OfficerNov 03 '26Option Exercise11.8216,207191,56716,207Nov 04 04:10 PM
Yarwood JeremyChief Scientific OfficerNov 04 '26Sale12.679,051114,6760Nov 04 04:10 PM
Yarwood JeremyOfficerNov 04 '26Proposed Sale12.679,051114,637Nov 04 11:23 AM
Hastings Gregory SVP, Animal HealthOct 29 '26Option Exercise12.211,21114,78633,786Oct 30 03:33 PM
Woteki Catherine EDirectorOct 29 '26Option Exercise12.211,77621,68529,507Oct 30 03:08 PM
RODRIGUEZ RAFAEL ADirectorOct 29 '26Option Exercise12.211,77621,68531,211Oct 30 02:45 PM
Gupta AashimaDirectorOct 29 '26Option Exercise12.211,77621,68538,180Oct 30 06:47 AM
Green Ronald DDirectorOct 29 '26Option Exercise12.211,77621,68529,044Oct 30 06:43 AM
CAPELLO JEFFREY DDirectorOct 29 '26Option Exercise12.211,77621,68542,892Oct 30 06:39 AM
BOREL JAMES CDirectorOct 29 '26Option Exercise12.211,77621,685106,737Oct 30 06:34 AM
Bernard ThierryFormer DirectorOct 28 '26Proposed Sale12.1916,937206,521Oct 28 03:01 PM
Hastings Gregory SVP, Animal HealthOct 14 '26Option Exercise12.002873,44432,655Oct 23 06:55 AM
Nassif MikhealCEOOct 09 '26Buy11.955056,0351,579Oct 09 07:24 PM
Nassif MikhealCEOAug 04 '26Buy11.813704,3701,074Aug 06 08:16 AM
Rocklin Amy MFormer OfficerJun 03 '26Proposed Sale8.7930,337266,559Jun 03 03:15 PM
Rocklin Amy MFormer OfficerMay 29 '26Proposed Sale9.1887,681805,154May 29 02:20 PM
Rocklin Amy MFormer Chief Legal OfficerMay 18 '26Option Exercise9.2935,183326,85092,423May 19 08:37 AM
Moylan John PatrickChief Accounting OfficerMay 04 '26Option Exercise9.534,55843,43818,905May 05 10:06 AM
Nassif MikhealCEOFeb 17 '26Buy10.9423252704Feb 17 03:12 PM
Nassif MikhealCEOJan 26 '26Buy9.8625246657Feb 02 04:36 PM
Nassif MikhealCEOFeb 02 '26Buy10.0024240681Feb 02 04:36 PM
Nassif MikhealCEOJan 16 '26Buy9.331371,279632Jan 16 09:04 AM
Naemura David H.Former CFODec 01 '25Option Exercise5.9812,91277,21493,936Dec 02 11:45 AM
Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
CEOMr. Mikhael Nassif
CFO & Senior Vice PresidentMr. R. Bryan Riggsbee CPA
J.D.Ms. Jennifer Evans Stacey Esq.
Senior VP & GM of Global Food SafetyDr. Tamara A. Ranalli Ph.D.
VPMr. John Moylan